CFG Wealth Management Services’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.1K Buy
+800
New +$14.4K 0.01% 121
2026
Q2
– Sell
-800
Closed -$9.9K – 82
2026
Q1
$9.9K Hold
800
– – 0.01% 135
2025
Q4
$10.1K Hold
800
– – 0.01% 140

Other funds holding AMRX

CFG Wealth Management Services's AMRX Position: Q3 2026 in Review

CFG Wealth Management Services opened a new position in Amneal Pharmaceuticals (AMRX) in Q3 2026: 800 shares worth $16.1K. The stake represents 0.01% of the portfolio and ranks #121 among its holdings. This is a return to the name: CFG Wealth Management Services previously reported a position in AMRX as recently as Q1 2026.

CFG Wealth Management Services first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. 334 funds tracked by Wall St. Rank hold AMRX as of Q3 2026.

  • CFG Wealth Management Services held 800 shares of Amneal Pharmaceuticals worth $16.1K as of Q3 2026.
  • Amneal Pharmaceuticals was a new CFG Wealth Management Services position in Q3 2026.
  • Amneal Pharmaceuticals made up 0.01% of CFG Wealth Management Services's portfolio in Q3 2026, its #121 holding.
  • CFG Wealth Management Services first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 334 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2026.

Based on CFG Wealth Management Services's 13F filing for Q3 2026, filed 21 Oct 2026.